<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>https://ecency.com</link><image><url>https://ecency.com/logo512.png</url><title>RSS Feed</title><link>https://ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Mon, 07 Sep 2026 16:03:42 GMT</lastBuildDate><atom:link href="https://ecency.com/created/hercloninjection/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Targeted Therapies Revolutionizing HER2-Positive Advanced Breast Cancer Care]]></title><description><![CDATA[One of the most common cancers to affect women worldwide, breast cancer can take many different forms, each of which requires a different strategy to treatment. Among these, HER2-positive breast cancer]]></description><link>https://ecency.com/@mrmed/targeted-therapies-revolutionizing-her2-positive</link><guid isPermaLink="true">https://ecency.com/@mrmed/targeted-therapies-revolutionizing-her2-positive</guid><category><![CDATA[mrmed]]></category><dc:creator><![CDATA[mrmed]]></dc:creator><pubDate>Mon, 04 Sep 2023 07:54:18 GMT</pubDate></item></channel></rss>